Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 02, 2012 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at 11th Annual Needham Healthcare Conference

CHARLOTTE, N.C., April 2, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 11th Annual Needham Healthcare Conference at 10:00 AM ET on...
March 28, 2012 18:39 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Receives Complete Response Letter from Food and Drug Administration for Northera(TM) (droxidopa) Capsules

CHARLOTTE, N.C., March 28, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete...
March 12, 2012 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at Roth 24th Annual OC Growth Stock Conference

CHARLOTTE, N.C., March 12, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced Keith Schmidt, VP Marketing and Sales, is scheduled to present at the Roth 24th...
March 07, 2012 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at Cowen and Company 32nd Annual Healthcare Conference

CHARLOTTE, N.C., March 7, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced Dr. Simon Pedder, president and CEO, is scheduled to present at the Cowen and...
March 06, 2012 16:05 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Reports Fourth Quarter and Full Year 2011 Results

CHARLOTTE, N.C., March 6, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the fourth quarter and full year 2011 and will host a...
March 02, 2012 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2011 Results

CHARLOTTE, N.C., March 2, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it plans to release fourth quarter and full year 2011 results after the market...
February 23, 2012 17:05 ET | Source: Chelsea Therapeutics

FDA Advisory Panel Recommends Approval of Chelsea's NORTHER(TM) (droxidopa) for the Treatment of Symptomatic Neurogenic OH

CHARLOTTE, N.C., Feb. 23, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs...
February 21, 2012 08:14 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Discuss NORTHERA(TM) (droxidopa) NDA for the Treatment of Symptomatic Neurogenic OH at FDA Advisory Committee Meeting on February 23

CHARLOTTE, N.C., Feb. 21, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) will meet with the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs...
February 16, 2012 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at Leerink Swann 2012 Global Healthcare Conference

CHARLOTTE, N.C., Feb. 16, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced Dr. Simon Pedder, president and CEO, is scheduled to present at the Leerink Swann...
February 13, 2012 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics CEO to Review NORTHERA(TM) NDA and Provide an Update on Upcoming Advisory Committee Meeting During Presentation at BIO CEO

CHARLOTTE, N.C., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that during a presentation at the 14th Annual BIO CEO and Investor Conference...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right